Press Release: OrSense : CSL Plasma Selects OrSense NBM200 Non-invasive Hemoglobin Testing Device

PETACH TIKVA, Israel, October 14, 2014 /PRNewswire/ -- OrSense Ltd., developer of solutions for non-invasive measurements of hemoglobin, today announced that CSL Plasma, Germany, has completed the transition to OrSense's NBM200 Hb testing device for screening of Hb levels in plasma...